Melody Dai

Executive Director, Regulatory Affairs at Adverum Biotechnologies

Speaker

Dr. Qing-Hong (Melody) Dai currently serves as Executive Director of Regulatory Affairs at Adverum Biotechnologies. She brings diverse experience in global regulatory affairs and drug development in the areas of ophthalmology, oncology, hematology and rare diseases. She spearheads the development and execution of CMC regulatory strategies for INDs, CTAs, and market applications throughout the clinical and commercial lifecycle management. Holding a Ph.D. in Biophysical Chemistry from Rutgers University and a B.S. in Chemistry from Peking University.